MiramarLab Florida Plantimex Mamisan Lidocaine Ointment Containers Recall 2025
MiramarLab, of Doral, FloridaIssued December 18, 2025Updated Reviewed by the Recall Watch editorial team
MiramarLab, of Doral, Florida Plantimex Recalls Mamisan Lidocaine Ointment Containers Due to Risk of Serious Injury or Death from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging — recalled per CPSC on 12/18/2025. Reason: The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children..
- Agency
- CPSC
- Issued
- Dec 18, 2025
- Brand
- MiramarLab, of Doral, Florida
- States affected
- 1
Steps to take for this recall
Stop using it
Take it out of rotation. Don't consume, wear, or operate.
Verify the match
Compare lot numbers, UPCs, and dates against your product.
Return or dispose
Follow the manufacturer's instructions to refund or safely dispose.
Free case review
Did you or someone in your household buy this product?
- Free
- No obligation
- Licensed attorneys
Attorney advertising.DetailsHide
Recall Watch is not a law firm and does not provide legal or medical advice. Free case reviews are provided by independent licensed attorneys; Recall Watch may receive a referral fee. Prior results do not guarantee a similar outcome. Submitting this form does not create an attorney-client relationship. See our terms and privacy policy.
What's recalled
This recall involves Mamisan Pain Relieving Topical Ointment jars. The ointment comes in an orange container with a white continuous thread lid and has the Mamisan trademark printed on top of the lid and on the label. The ointment was sold in a 3.52 ounce plastic jar. The wraparound label includes instructions and drug facts. Only jars with UPC code 860006498115 are included in the recall.
Ad
Restock lidocaine ointment
Lidocaine ointment from other brands, searched on Amazon.
Need it delivered? Start a free Amazon Prime trial.
Why it was recalled
The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
Where was it sold1 state
More recalls like this4 related — by brand, contaminant, and category
Frequently asked questions
Is the MiramarLab, of Doral, Florida recall still active?
Yes, this recall is currently active as of December 18, 2025. Do not use or consume the affected product.
How do I know if my MiramarLab, of Doral, Florida is affected?
All units of MiramarLab, of Doral, Florida matching the description above are affected.
What should I do if I have the recalled MiramarLab, of Doral, Florida?
Do not consume or use this product. Return it to the store for a full refund, or dispose of it safely.